Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary disease

European Journal of Clinical Pharmacology

Volumn 54, Issue 11, 1999, Pages 829-833

  Cazzola, M ^a,d   Calderaro, F ^c   Califano, C ^c   Di Pema, F ^c   Vinciguerra, A ^c   Donner, C F ^b   Matera, M G ^a  

^a Rehabilitation Institute   (Italy)

^b IRCCS   (Italy)

^c CARDARELLI HOSPITAL   (Italy)

^d Centro Medico di Riabilitazione   (Italy)

Author keywords

Bambuterol; COPD; Salmeterol

Indexed keywords

BAMBUTEROL; SALMETEROL;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; METERED DOSE INHALER; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TACHYCARDIA; TREMOR;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADULT; AGED; ALBUTEROL; ARRHYTHMIA; BRONCHODILATOR AGENTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FORCED EXPIRATORY FLOW RATES; FORCED EXPIRATORY VOLUME; HEART RATE; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; TERBUTALINE; TIME FACTORS; TREMOR;

EID: 0032948722     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050561     Document Type: Article

References (23)

1. 1. Coleman RA, Johnson M, Nials AT, Vardey CJ (1996) Exosites: their current status, and their relevance to the duration of action of long-acting beta2-adrenoceptor agonists. Trends Pharmacol Sci 17: 324-330
2. 2. Sitar DS (1996) Clinical pharmacokinetics of bambuterol, Clin Pharmacokinet 31: 246-256
3. 3. Svensson LA (1991) Mechanism of action of bambuterol: a beta-agonist prodrug with sustained lung affinity. Agents Actions 34 [Suppl]: 71-78
4. 4. Cazzola M, Santangelo G, Piccolo A, Salzillo A, Matera MG, D'Amato G et al (1994) Effect of salmeterol and formoterol in patients with chronic obstructive pulmonary disease. Pulm Pharmcol 7: 103-107
5. 5. Jack D (1991) A way of looking at agonism and antagonism: lesson from salbutamol, salmeterol and other β-adrenoceptor agonists. Br J Clin Pharmcol 31: 501-514
6. 6. Anderson GP, Lindón A, Rabe KF (1994) Why are long-acting β-adrenoceptor agonists long-acting? Eur Respir J 7: 569-578
7. 7. Cazzola M, Spina D, Matera MG (1997) The use of bronchodilators in stable chronic obstructive pulmonary disease. Pulm Pharmacol Ther 10: 129-144
8. 8. Matera MG, Cazzola M, Vinciguerra A, Di Perna F, Calderaro F, Caputi M et al (1995) A comparison of the bronchodilating effects of salmeterol, salbutamol and ipratropium bromide in patients with chronic obstructive pulmonary disease. Pulm Pharmacol 8: 267-271
9. 9. Cazzola M, Matera MG, Santangelo G, Vinciguerra A, Rossi F, D'Amato G (1995) Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose-response study. Respir Med 89: 357-362
10. 10. Matera MG, Caputi M, Cazzola M (1996) A combination with clinical recommended dosages of salmeterol and ipratropium is not more effective than salmeterol alone in patients with chronic obstructive pulmonary disease. Respir Med 90: 497-499
11. 11. Cazzola M, Matera MG, Di Perna F, Calderaro F, Califano C, Vinciguerra A (1998) A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease. Respir Med 92: 354-357
12. 12. McDonald CF, Pierce RJ, Thompson PJ, Allan D, Bowler S, Breslin AB et al (1997) Comparison of oral bambuterol and terbutaline in elderly patients with chronic reversible airflow obstruction. J Asthma 34: 53-59
13. 13. American Thoracic Society (1995) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 152: S72-S120
14. 14. American Thoracic Society (1987) Standardisation of spirometry - 1987 update. Am Rev Respir Dis 136: 1285-1298
15. 15. Koch GG (1972) The use of nonparametric methods in the statistical analysis of the two period change-over design. Biometrics 28: 577-584
16. 16. Roche N, Chinet T, Huchon G (1997) Ambulatory inhalation therapy in obstructive lung diseases. Respiration 64: 121-130
17. 2-adrenoceptor agonists. Lung 168 [Suppl]: 168-176
18. 18. van der Palen J, Klein JJ, Kerkhoff AH, van Herwsarden CL (1995) Evaluation of the effectiveness of four different inhalers in patients with chronic obstructive pulmonary disease. Thorax 50: 1183-1187
19. 19. Kelloway JS, Wyatt RA, Adlis SA, (1994) Comparison of patients' compliance with prescribed oral and inhaled asthma medications. Arch Int Med 154: 1349-1352
20. 20. Dekker FW, Dielman FE, Kaptein AA Mulder JD (1993) Compilence with pulmonary medication in general practice. Eur Respir J 6: 886-890
21. 21. Sitar DS, Aoki FY, Warren CP, Knight A, Grossman RF, Alexander M et al (1993) A placebo-controlled dose-finding-study with bambuterol in elderly patients with asthma. Chest 103: 771-776
22. 22. Cazzola M, Di Perna F, Noschese P, Vinciguerra A, Calderaro F, Girbino G et al (1998) Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD. Eur Respir J 11: 1337-1341
23. 23. Ahrens RC (1990) Skeletal muscle tremor and the influence of adrenergic drugs. J Asthma 27: 11-20